Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels

Overview of attention for article published in Orphanet Journal of Rare Diseases, August 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 3 news outlets
twitter: 9 X users

video: 1 YouTube creator

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 18 Mendeley

Summary News X YouTube Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Descubren nuevas posibilidades terapéuticas en la neurodegeneración asociada a pantotenato kinasa

Diario Siglo XXI, 16 Sep 2022

MADRID, 16 (EUROPA PRESS) Un equpo de investigadores del CIBERER ha demostrado que varios compuestos comerciales pueden…

Descubren nuevas posibilidades terapéuticas en la neurodegeneración asociada a pantotenato kinasa

Infosalus.com, 16 Sep 2022

MADRID, 16 Sep. (EUROPA PRESS) - Un equpo de investigadores del CIBERER ha demostrado que varios compuestos comerciales pueden…

Descubren nuevas posibilidades terapéuticas en la neurodegeneración asociada a pantotenato kinasa

NoticiasDe.es, 16 Sep 2022

MADRID, 16 (EUROPA PRESS) Un equpo de investigadores del CIBERER ha demostrado que varios compuestos comerciales pueden…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.